OUTCOMES AFTER TRANSTHORACIC, PERIPHERAL VASCULAR AND TRANSFEMORAL TRANSCATHETER AORTIC VALVE IMPLANTATION: A PROPENSITY ANALYSIS FROM FRANCE TAVI REGISTRY
2018
According to PARTNER 2 (2016), Transcatheter Aortic Valve Replacement (TAVR) is non inferior to surgery in intermediate risk patient. Furthermore, TAVR through a transfemoral access might be superior to surgery (second cohort, not designed for superiority) while TAVR through other access sites,
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI